International Clinics
Daily
EMA committee backs extending AstraZeneca's H5N1 pandemic nasal flu vaccine to adults
On 15 October 2026 the EMA's human medicines committee adopted a positive opinion extending the indication of AstraZeneca's H5N1 pandemic vaccine.